Sell Bristol Myers March $50 Call

By Joe Duarte • February 10, 2017

It’s time to take profits on the Bristol Myers March 17, 2017 Call Option with a $50 strike price (BMY_170317C005000). I recommended this option on 1/20/17 at $2.04. The early price on 2/10/17 was $2.56. The profit for this three week holding period was 25.49%.

I will have more on BMY in Monday’s edition of Breakthrough Tech Weekly.

Stock Talk

Comments Oldest First

Comments Guidelines

DR083157

02/10/17 ‐ 11:25am ET February 10, 2017 at 11:25am ET

I sold out, but curious why saying sell. Are you afraid going to go back down? I was feeling safe to ride it to the end.

Paul Hedgi

02/10/17 ‐ 12:52pm ET February 10, 2017 at 12:52pm ET

THANKS FOR TRADE

Joe Duarte

02/10/17 ‐ 2:49pm ET February 10, 2017 at 2:49pm ET

Always sell while there is profit. It’s getting close to that magic 30 days when time premium fades and option prices fall precipitously. I’m not done with BMY yet.

BMOFI48

02/14/17 ‐ 1:46pm ET February 14, 2017 at 1:46pm ET

Joe
Maybe I missed something or do not know where to look, but I have been searching for your thoughts on BMY. You indicated “I will have more on BMY in Monday’s edition of Breakthrough Tech Weekly”, but have not seen anything. Bruce

Jim Pearce

02/14/17 ‐ 2:27pm ET February 14, 2017 at 2:27pm ET

Hi Bruce. I liked Joe’s article so much on BMY that I moved into the monthly issue of BTP that will be published this Thursday, so please look for it there. My apologies for the confusion, my fault all the way.

BMOFI48

02/14/17 ‐ 2:39pm ET February 14, 2017 at 2:39pm ET

No Worries. She took a nice jump today and I was wondering if everyone else read Joe’s report and jumped on it. Wanted to give him credit if his report was positive! Bruce

Add New Comments

You must be logged in to post to Stock Talk OR create an account

About The Author

Joe Duarte

Bio | Archive

Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.